A detailed history of Rafferty Asset Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 15,984 shares of TECH stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,984
Previous 17,133 6.71%
Holding current value
$1.14 Million
Previous $1.23 Million 4.07%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$70.96 - $82.35 $81,533 - $94,620
-1,149 Reduced 6.71%
15,984 $1.28 Million
Q2 2024

Aug 13, 2024

BUY
$62.12 - $84.15 $57,150 - $77,418
920 Added 5.67%
17,133 $1.23 Million
Q1 2024

May 13, 2024

BUY
$65.98 - $77.09 $7,587 - $8,865
115 Added 0.71%
16,213 $1.14 Million
Q4 2023

Feb 13, 2024

SELL
$52.83 - $78.22 $17,328 - $25,656
-328 Reduced 2.0%
16,098 $1.24 Million
Q3 2023

Nov 13, 2023

BUY
$67.52 - $89.42 $77,310 - $102,385
1,145 Added 7.49%
16,426 $1.12 Million
Q2 2023

Aug 11, 2023

BUY
$73.76 - $85.98 $87,848 - $102,402
1,191 Added 8.45%
15,281 $1.25 Million
Q1 2023

May 11, 2023

BUY
$71.62 - $86.62 $42,399 - $51,279
592 Added 4.39%
14,090 $1.05 Million
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $918,266 - $4.01 Million
11,383 Added 538.2%
13,498 $1.12 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $328,594 - $455,721
1,163 Added 122.16%
2,115 $601,000
Q2 2022

Aug 12, 2022

SELL
$322.67 - $449.65 $494,975 - $689,763
-1,534 Reduced 61.71%
952 $330,000
Q1 2022

May 13, 2022

SELL
$353.85 - $487.79 $118,185 - $162,921
-334 Reduced 11.84%
2,486 $1.08 Million
Q4 2021

Feb 10, 2022

BUY
$456.15 - $525.06 $720,717 - $829,594
1,580 Added 127.42%
2,820 $1.46 Million
Q3 2021

Nov 10, 2021

BUY
$444.87 - $538.88 $551,638 - $668,211
1,240 New
1,240 $601,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.